Hindustan Bio Sciences Board Approves 55% Capital Reduction Scheme

Board approved a Scheme of Reduction of Capital, cancelling 56,37,940 equity shares of Rs 2 each pro rata and consolidating the remaining shares into Rs 10 each; shareholders will receive 9 Rs 10 shares for every 100 Rs 2 shares. Paid-up capital will reduce from Rs 2.1 Cr to Rs 0.9 Cr, with Rs 1.1 Cr set off against accumulated losses of Rs 1.2 Cr. Shareholding percentages will remain unchanged. The scheme requires shareholder, NCLT and other regulatory approvals. No consideration will be paid for cancelled shares, and the record date, implementation timeline and treatment of fractional entitlements remain to be finalized.